{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:39:45Z","timestamp":1789007985184,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12149-024-01941-5","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T06:01:46Z","timestamp":1716012106000},"page":"726-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of hormone therapy on physiological uptake of the endometrium on [18F]F-FDG PET in postmenopausal women"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4950-6654","authenticated-orcid":false,"given":"Ryusuke","family":"Nakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi W.","family":"Nobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"key":"1941_CR1","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jama.288.7.872","volume":"288","author":"HD Nelson","year":"2002","unstructured":"Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002;288:872\u201381. https:\/\/doi.org\/10.1001\/jama.288.7.872.","journal-title":"JAMA"},{"key":"1941_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.7326\/0003-4819-130-7-199904060-00002","volume":"130","author":"NL Keating","year":"1999","unstructured":"Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med. 1999;130:545\u201353. https:\/\/doi.org\/10.7326\/0003-4819-130-7-199904060-00002.","journal-title":"Ann Intern Med"},{"key":"1941_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.6118\/jmm.20000","volume":"26","author":"SR Lee","year":"2020","unstructured":"Lee SR, Cho MK, Cho YJ, Chun S, Hong S-H, Hwang KR, et al. The 2020 menopausal hormone therapy guidelines. J Menopaus Med. 2020;26:69.","journal-title":"J Menopaus Med"},{"key":"1941_CR4","first-page":"389","volume":"47","author":"K Hirota","year":"1995","unstructured":"Hirota K, Honjo H, Shintani M. Factors affecting menopause. Adv Obstet Gynecol. 1995;47:389\u201392.","journal-title":"Adv Obstet Gynecol"},{"key":"1941_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0378-5122(95)00952-3","volume":"23","author":"JV Jolleys","year":"1996","unstructured":"Jolleys JV, Olesen F. A comparative study of prescribing of hormone replacement therapy in USA and Europe. Maturitas. 1996;23:47\u201353. https:\/\/doi.org\/10.1016\/0378-5122(95)00952-3.","journal-title":"Maturitas"},{"key":"1941_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial. JAMA. 2002;288:321\u201333. https:\/\/doi.org\/10.1001\/jama.288.3.321.","journal-title":"JAMA"},{"key":"1941_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.maturitas.2014.07.002","volume":"79","author":"L Ameye","year":"2014","unstructured":"Ameye L, Antoine C, Paesmans M, de Azambuja E, Rozenberg S. Menopausal hormone therapy use in 17 European countries during the last decade. Maturitas. 2014;79:287\u201391. https:\/\/doi.org\/10.1016\/j.maturitas.2014.07.002.","journal-title":"Maturitas"},{"key":"1941_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.maturitas.2014.08.002","volume":"79","author":"W Peng","year":"2014","unstructured":"Peng W, Adams J, Hickman L, Sibbritt DW. Complementary\/alternative and conventional medicine use amongst menopausal women: results from the Australian Longitudinal Study on Women\u2019s Health. Maturitas. 2014;79:340\u20132. https:\/\/doi.org\/10.1016\/j.maturitas.2014.08.002.","journal-title":"Maturitas"},{"key":"1941_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.maturitas.2015.11.010","volume":"84","author":"C Antoine","year":"2016","unstructured":"Antoine C, Ameye L, Paesmans M, de Azambuja E, Rozenberg S. Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries. Maturitas. 2016;84:81\u20138. https:\/\/doi.org\/10.1016\/j.maturitas.2015.11.010.","journal-title":"Maturitas"},{"key":"1941_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1148\/radiology.197.3.7480726","volume":"197","author":"D Levine","year":"1995","unstructured":"Levine D, Gosink BB, Johnson LA. Change in endometrial thickness in postmenopausal women undergoing hormone replacement therapy. Radiology. 1995;197:603\u20138.","journal-title":"Radiology"},{"key":"1941_CR11","first-page":"266","volume":"45","author":"H Lerman","year":"2004","unstructured":"Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre-and postmenopausal patients: assessment by PET\/CT. J Nucl Med. 2004;45:266\u201371.","journal-title":"J Nucl Med"},{"issue":"866","key":"1941_CR12","first-page":"1","volume":"1996","author":"Research on the menopause in the","year":"1990","unstructured":"Research on the menopause in the. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1990;1996(866):1\u2013107.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"1941_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12149-008-0227-z","volume":"23","author":"Y Liu","year":"2009","unstructured":"Liu Y. Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls. Ann Nucl Med. 2009;23:107\u201312. https:\/\/doi.org\/10.1007\/s12149-008-0227-z.","journal-title":"Ann Nucl Med"},{"key":"1941_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1148\/rg.2017160059","volume":"37","author":"A Lakhani","year":"2017","unstructured":"Lakhani A, Khan SR, Bharwani N, Stewart V, Rockall AG, Khan S, et al. FDG PET\/CT pitfalls in gynecologic and genitourinary oncologic imaging. Radiographics. 2017;37:577\u201394. https:\/\/doi.org\/10.1148\/rg.2017160059.","journal-title":"Radiographics"},{"key":"1941_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/01.rlu.0000251870.33485.69","volume":"32","author":"A Julian","year":"2007","unstructured":"Julian A, Payoux P, Rimailho J, Paynot N, Esquerre J. Uterine uptake of F-18 FDG on positron emission tomography induced by an intrauterine device: unusual pitfall. Clin Nucl Med. 2007;32:128\u20139. https:\/\/doi.org\/10.1097\/01.rlu.0000251870.33485.69.","journal-title":"Clin Nucl Med"},{"key":"1941_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","volume":"91","author":"E Weiderpass","year":"1999","unstructured":"Weiderpass E, Adami HO, Baron JA, Magnusson C, Bergstr\u00f6m R, Lindgren A, et al. Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst. 1999;91:1131\u20137. https:\/\/doi.org\/10.1093\/jnci\/91.13.1131.","journal-title":"J Natl Cancer Inst"},{"key":"1941_CR17","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJM199811263392207","volume":"339","author":"CK Osborne","year":"1998","unstructured":"Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339:1609\u201318.","journal-title":"N Engl J Med"},{"key":"1941_CR18","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1093\/oxfordjournals.humrep.a019084","volume":"11","author":"I Noci","year":"1996","unstructured":"Noci I, Borri P, Scarselli G, Chieffi O, Bucciantini S, Biagiotti R, et al. Uterus and endometrium: morphological and functional aspects of the endometrium of asymptomatic post-menopausal women: does the endometrium really age? Hum Reprod. 1996;11:2246\u201350.","journal-title":"Hum Reprod"},{"key":"1941_CR19","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1210\/jc.2002-021890","volume":"88","author":"M von Wolff","year":"2003","unstructured":"von Wolff M, Ursel S, Hahn U, Steldinger R, Strowitzki T. Glucose transporter proteins (GLUT) in human endometrium: expression, regulation, and function throughout the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab. 2003;88:3885\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"1941_CR20","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1210\/en.2010-1266","volume":"152","author":"AI Frolova","year":"2011","unstructured":"Frolova AI, Moley KH. Quantitative analysis of glucose transporter mRNAs in endometrial stromal cells reveals critical role of GLUT1 in uterine receptivity. Endocrinology. 2011;152:2123\u20138.","journal-title":"Endocrinology"},{"key":"1941_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1677\/joe.0.1820467","volume":"182","author":"RA Medina","year":"2004","unstructured":"Medina RA, Meneses AM, Vera JC, G\u00fazman C, Nualart F, Rodriguez F, et al. Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells. J Endocrinol. 2004;182:467\u201378.","journal-title":"J Endocrinol"},{"key":"1941_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00259-004-1703-x","volume":"32","author":"S Nishizawa","year":"2005","unstructured":"Nishizawa S, Inubushi M, Okada H. Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imaging. 2005;32:549\u201356. https:\/\/doi.org\/10.1007\/s00259-004-1703-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1941_CR23","doi-asserted-by":"publisher","first-page":"101150","DOI":"10.1016\/j.jbc.2021.101150","volume":"297","author":"I Tamura","year":"2021","unstructured":"Tamura I, Fujimura T, Doi-Tanaka Y, Takagi H, Shirafuta Y, Kajimura T, et al. The essential glucose transporter GLUT1 is epigenetically upregulated by C\/EBP\u03b2 and WT1 during decidualization of the endometrium. J Biol Chem. 2021;297:101150.","journal-title":"J Biol Chem"},{"key":"1941_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.214.1.r00ja4429","volume":"214","author":"SM Ascher","year":"2000","unstructured":"Ascher SM, Imaoka I, Lage JM. Tamoxifen-induced uterine abnormalities: the role of imaging. Radiology. 2000;214:29\u201338. https:\/\/doi.org\/10.1148\/radiology.214.1.r00ja4429.","journal-title":"Radiology"},{"key":"1941_CR25","first-page":"1238","volume":"44","author":"D Vranjesevic","year":"2003","unstructured":"Vranjesevic D, Schiepers C, Silverman DH, Quon A, Villalpando J, Dahlbom M, et al. Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. J Nucl Med. 2003;44:1238\u201342.","journal-title":"J Nucl Med"},{"key":"1941_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s0378-5122(96)01067-5","volume":"25","author":"C Nagata","year":"1996","unstructured":"Nagata C, Matsushita Y, Shimizu H. Prevalence of hormone replacement therapy and user\u2019s characteristics: a community survey in Japan. Maturitas. 1996;25:201\u20137. https:\/\/doi.org\/10.1016\/s0378-5122(96)01067-5.","journal-title":"Maturitas"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-01941-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-024-01941-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-01941-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:20:28Z","timestamp":1724404828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-024-01941-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1941"],"URL":"https:\/\/doi.org\/10.1007\/s12149-024-01941-5","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ryusuke Nakamoto receives grants from Midtown Clinic Medical Corporation and Kyoto ProMed Co., Ltd. during the conduct of the study, and grants from Novartis AG outside the submitted work. Masahiro Yakami, Tomomi W Nobashi, and Hiroyoshi Isoda receive grants from Midtown Clinic Medical Corporation and Kyoto ProMed Co., Ltd. during the conduct of the study. Yuji Nakamoto receives grants from Novartis AG and Canon Medical Systems Corporation outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}